Literature DB >> 16198621

Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases.

Shuichi Seki1, Takuya Kitada, Hiroki Sakaguchi.   

Abstract

Oxidative stress may play an important role in the progression of simple steatosis to non-alcoholic steatohepatitis (NASH). Oxidative stress is generated through multiple sources, including oxidation of free fatty acids, cytochrome P4502E1, iron overload, and necro-inflammatory cytokines including tumor necrosis factor-alpha. Oxidative stress may trigger damage to cellular membranes and nuclear DNA, which results in lipid peroxidation and oxidative DNA damage, respectively. Here, we present our data on intrahepatic localization and clinico-pathological significance of oxidative stress-induced cellular damage in the patients with non-alcoholic fatty liver diseases (NAFLD). Our subjects were 23 patients with non-alcoholic simple fatty liver, 17 with NASH, and 7 with normal liver (control). Hepatic expression of 4-hydroxy-2'-nonenal (HNE) and 8-hydroxydeoxyguanosine (8-OHdG), as reliable markers of lipid peroxidation and oxidative DNA damage, was in situ detected by using commercially available monoclonal antibodies. While no HNE adducts were observed in control livers, they were frequently detected in NAFLD. In NASH, the localization of the HNE adducts was in the cytoplasm of sinusoidal cells and hepatocytes with a predominance in zone 3. The grade of necro-inflammation as well as the stage of fibrosis significantly correlated with the HNE labeling index. With respect to 8-OHdG, although no 8-OHdG expression was observed in normal liver and only a few in non-alcoholic simple fatty liver, 11 of 17 patients with NASH (65%) exhibited nuclear expression of 8-OHdG in hepatocytes and sinusoidal cells in areas of active inflammation. The 8-OHdG index significantly correlated with the grade of necro-inflammation, but not with the stage of fibrosis. Our observations suggest that oxidative cellular damage occurs frequently in livers with NAFLD and may be associated with some clinico-pathological features of NAFLD including liver fibrosis and possibly, hepatocarcinogenesis.

Entities:  

Year:  2005        PMID: 16198621     DOI: 10.1016/j.hepres.2005.09.020

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  31 in total

1.  Oxidative stress profile in the post-operative patients with biliary atresia.

Authors:  Takahiro Asakawa; Yoshiaki Tanaka; Kimio Asagiri; Hidefumi Kobayashi; Ken Tanikawa; Minoru Yagi
Journal:  Pediatr Surg Int       Date:  2008-11-14       Impact factor: 1.827

2.  Down-regulation of hepcidin in porphyria cutanea tarda.

Authors:  Richard S Ajioka; John D Phillips; Robert B Weiss; Diane M Dunn; Maria W Smit; Sean C Proll; Michael G Katze; James P Kushner
Journal:  Blood       Date:  2008-09-22       Impact factor: 22.113

Review 3.  DNA damage response and sphingolipid signaling in liver diseases.

Authors:  Masayuki Nagahashi; Yasunobu Matsuda; Kazuki Moro; Junko Tsuchida; Daiki Soma; Yuki Hirose; Takashi Kobayashi; Shin-Ichi Kosugi; Kazuaki Takabe; Masaaki Komatsu; Toshifumi Wakai
Journal:  Surg Today       Date:  2015-10-29       Impact factor: 2.549

4.  Severity of non-alcoholic fatty liver disease is associated with high systemic levels of tumor necrosis factor alpha and low serum interleukin 10 in morbidly obese patients.

Authors:  Gabriela Paredes-Turrubiarte; Antonio González-Chávez; Ruy Pérez-Tamayo; Beatriz Y Salazar-Vázquez; Vito S Hernández; Nayeli Garibay-Nieto; José Manuel Fragoso; Galileo Escobedo
Journal:  Clin Exp Med       Date:  2015-04-18       Impact factor: 3.984

5.  Comparative redox status in alcoholic liver disease and nonalcoholic fatty liver disease.

Authors:  Payal Bhardwaj; Kaushal Madan; Sandeep Thareja; Yogendra Kumar Joshi; Anoop Saraya
Journal:  Hepatol Int       Date:  2008-02-27       Impact factor: 6.047

Review 6.  Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease.

Authors:  Harmeet Malhi; Gregory J Gores
Journal:  Semin Liver Dis       Date:  2008-10-27       Impact factor: 6.115

Review 7.  Fructose as a key player in the development of fatty liver disease.

Authors:  Metin Basaranoglu; Gokcen Basaranoglu; Tevfik Sabuncu; Hakan Sentürk
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

Review 8.  From fatty liver to fibrosis: a tale of "second hit".

Authors:  Metin Basaranoglu; Gökcen Basaranoglu; Hakan Sentürk
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

Review 9.  Reactive oxygen and nitrogen species in steatotic hepatocytes: a molecular perspective on the pathophysiology of ischemia-reperfusion injury in the fatty liver.

Authors:  Megan J Reiniers; Rowan F van Golen; Thomas M van Gulik; Michal Heger
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

10.  Increased carbonylation of the lipid phosphatase PTEN contributes to Akt2 activation in a murine model of early alcohol-induced steatosis.

Authors:  C T Shearn; R L Smathers; D S Backos; P Reigan; D J Orlicky; Dennis R Petersen
Journal:  Free Radic Biol Med       Date:  2013-07-17       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.